临床试验

Optimizing Y90 Therapy for Radiation Lobectomy

NCT：NCT04390724 · ACTIVE_NOT_RECRUITING

NCT编号NCT04390724

状态ACTIVE_NOT_RECRUITING

开始日期2020-07-17

完成时间2026-11-27

SponsorNorthwestern University (OTHER)

First posted2020-05-15

Last updated2026-09-16

简要摘要

HCC resection candidates with inadequate future liver remnant will be enrolled in this study. They will be treated with Y90 radioembolization to help grow the liver enough to undergo liver resection. There will be 2 Patient Groups. The first group of patients will be treated with Y90 dose and embolic load as per standard-of-care. The second group of patients will be treated with the optimal Y90 dose and embolic load found in Patient Group 1.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。